WBIO — WPD Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

FinancialsHighly SpeculativeMicro Cap

Brief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
01/10/2026 06:31
Brief: Mabion Signs About 2 Mln Zloty Deal With WPD Pharmaceuticals
17/04/2025 17:12
Brief: WPD Pharmaceuticals Signs Annex To License Agreement With Wake Forest University Health Sciences
16/05/2022 13:16
Brief: WPD Pharmaceuticals Announces Proposed Restructuring Of Polish Subsidiary
09/02/2022 12:32
Brief: WPD Pharmaceuticals Enters Into Amended And Restated Sublicense Agreement With Moleculin Biotech
25/01/2022 13:19
Brief: WPD Pharmaceuticals Announces Amended Sublicense Agreement With Moleculin Biotech For Wp1066, Wp1122 And Annamycin Drug Candidates
30/03/2021 13:09
Brief: Wpd And Cns Pharmaceuticals Announce Positive Opinion Of Polish Central Ethics Committee For Wpd-201 Study And Central Irb Study Level Approval For Cns-201 Study
18/02/2021 14:32
Brief: WPD Pharmaceuticals Engages Worldwide Clinical Trials As CRO For Further Support On Berubicin Trials
11/02/2021 14:11
Brief: Nordex Wins Order For 188 MW In Finland
07/01/2021 06:34
Brief: Cns Pharmaceuticals Says University Research Confirms Active Compound In WP1122 Completely Prevents Coronavirus Replication In Vitro
13/04/2020 14:22
Brief: WPD Pharmaceuticals Partners With CNS Pharmaceuticals On Drug Development For Coronavirus And Other Antiviral Indications
24/03/2020 08:43
Brief: Cns Pharma Announces Collaboration With European Partner To Expand Trials To Pediatric Brain Tumors
11/02/2020 13:30
Brief: Wpd Pharmaceuticals’ New Discovery For Cancer Targeting Drugs Is Granted Patent
09/01/2020 12:48